Based on a real time PCR analysis we identified a potential molecular signature defined by SOX2 and ALDH2, validated at protein level in tumor tissue sections, that could be useful on the recognition of patients with muscle-invasive tumors that are more prone to experience disease progression or metastasis development. Here, SOX2 is linked to neoplasm.